(19)
(11) EP 4 387 998 A1

(12)

(43) Date of publication:
26.06.2024 Bulletin 2024/26

(21) Application number: 21954398.0

(22) Date of filing: 20.08.2021
(51) International Patent Classification (IPC): 
C07K 16/28(2006.01)
A61K 39/42(2006.01)
 C07K 16/08(2006.01)
A61P 35/00(2006.01)
(52) Cooperative Patent Classification (CPC):
Y02A 50/30; A61P 35/00; C07K 16/2896; C07K 16/2809; C07K 2317/31; C07K 2317/76; C07K 2317/622; C07K 2319/03; C07K 2317/24
(86) International application number:
PCT/US2021/046855
(87) International publication number:
WO 2023/022729 (23.02.2023 Gazette 2023/08)
(84) Designated Contracting States:
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated Extension States:
BA ME
Designated Validation States:
KH MA MD TN

(71) Applicant: Tasrif Pharmaceutical, LLC
Farmingdale, NY 11735 (US)

(72) Inventors:
  • KARIM, Aftab, S.
    NY 11735 (US)
  • HOLGATE, Robert
    Cambridge CB22 3 AT (GB)
  • HEARN, Arron
    Cambridge CB22 3 AT (GB)

(74) Representative: Lapienis, Juozas 
MSP Europe UAB 21-92 Seimyniskiu Str.
09236 Vilnius
09236 Vilnius (LT)

   


(54) ANTIBODIES AND ANTIGEN BINDING FRAGMENTS AGAINST CD155 METHODS OF USE THEREOF